| Date | Title | Description |
| 13.07.2026 | OpenEvidence Launches EvidenceGrade to Bring Real-Time Source Quality Grading to Clinical AI | What You Should Know
Medical AI leader OpenEvidence has announced the commercial launch of EvidenceGrade, a new system capability that scores and visualizes the clinical certainty of cited medical literature in real time.
The feature direct... |
| 22.06.2026 | Baseten Raises $1.5 Billion Series F To Power AI Inference | Baseten announced that it has raised a $1.5 billion Series F financing round. The round was led by Altimeter Capital, Conviction, and Spark Capital. Sands Capital and Wellington Management also participated as co-leads. Other investors in t... |
| 16.06.2026 | Global AI Healthcare Set for Rapid Expansion in 2026 as Xunfei Healthcare (2506.HK) Launches V3.5 Upgrade for Scalable Real-World Applications | HONG KONG, June 16, 2026 /PRNewswire/ -- Xunfei Healthcare (2506.HK) officially launched Xunfei Spark Medical Model V3.5 on June 9. The upgrade focuses on two core areas of urgent demand: clinical diagnosis and treatment, and health managem... |
| 10.06.2026 | Zilliz Launches Vector Lakebase, Extending the World's Most Adopted Vector Database into a Unified Data Platform for AI | Available now in public preview on Zilliz Cloud, Vector Lakebase keeps production vector search at its core and adds shared lake-native storage and on-demand compute — bringing real-time serving, interactive discovery, and batch analytics o... |
| 14.05.2026 | Corti steps up its support for the next wave of healthcare startups as OpenAI pushes into the space and others retreat from Europe | As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 regulatory barrier and build on the vertical model that outscored OpenAI on its new healthc... |
| 13.05.2026 | Corti launches no-equity accelerator for healthcare AI startups | Healthtech startup Corti today announced the launch of the Startup Acceleration Program, a no-equity initiative providing healthcare AI builders worldwide with access to the same clinical-grade models that power AI for highly regulated syst... |
| 22.04.2026 | Treehub launches with Tim Draper and Anne Wojcicki to back the next wave of AI health founders
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Treehub, a new Stanford University-adjacent residency program backed by the AI Health Fund, launched today, with billionaire investor Tim Draper and 23andMe Holding Co. founder Anne Wojcicki among the high-profile names attached to an effor... |
| 01.04.2026 | Mount Sinai Integrates OpenEvidence AI Platform into Epic EHR for Enterprise-Wide Clinical Decision Support | What You Should Know
The Deployment: Mount Sinai Health System, one of the nation’s largest academic medical systems, is rolling out OpenEvidence, an AI-powered medical search and clinical decision-support platform, across its enterprise di... |
| 12.03.2026 | Wiley and OpenEvidence Partner to Integrate Peer-Reviewed Medical Research into Clinical AI | What You Should Know
The Deal: Academic publishing giant Wiley is licensing a massive portfolio of its scientific and medical content to OpenEvidence, the clinical AI platform used by more than 40% of U.S. physicians.
The Assets: The integr... |
| 04.03.2026 | Sol Endocrinology Highlights Why the Teen Years Are Especially Challenging for Type 1 Diabetes Care in Dallas Families | Supporting emotional well being is just as important as adjusting insulin doses.”
— Dr. Erin RoeDALLAS, TX, UNITED STATES, March 3, 2026 /EINPresswire.com/ -- Sol Endocrinology is bringing attention to one of the most vulnerable stages in t... |
| 27.01.2026 | Baseten Secures $300M, Valued at $5 Billion, as AI Inference Dominates | Baseten, a leading AI inference company, announced a massive $300 million funding round. This capital infusion propelled its valuation to $5 billion. Total funds secured now exceed $585 million. Baseten builds the critical software infrastr... |
| 26.01.2026 | Baseten Raises $300M in Funding | Baseten, a San Francisco, CA-based AI inference company supporting AI applications, raised $300M in funding, at $5 Billion valuation.
The round was led by IVP, CapitalG, and NVIDIA.
The raise brought the total amount to $585M to date.
The c... |
| 23.01.2026 | OpenEvidence Secures $250M, Valuation Soars to $12 Billion | OpenEvidence, an AI-powered medical platform, closed a $250 million Series D round. It now stands at a $12 billion valuation, becoming the highest-valued healthcare AI company. This funding, co-led by Thrive Capital and DST Global, propels ... |
| 23.01.2026 | Baseten: $300 Million At $5 Billion Valuation Raised As Inference Becomes Core AI Infrastructure | Baseten, an AI inference company focused on running modern models in production, has raised $300 million in new financing at a $5 billion valuation. IVP, CapitalG, and NVIDIA anchored the round, as demand accelerates for high-performance in... |
| 22.01.2026 | OpenEvidence: $250 Million Series D At $12 Billion Valuation Raised To Expand AI ‘Medical Superintelligence’ Platform for Doctors | OpenEvidence, an AI-powered medical search platform used by clinicians, said it has raised $250 million in a Series D financing that values the company at $12 billion, positioning it as the highest-valued healthcare AI company. Thrive Capit... |
| 21.01.2026 | Medical AI startup OpenEvidence doubles valuation to $12 billion in latest round | Jan 21 : OpenEvidence, an AI startup whose tools are used by U.S. physicians, has raised $250 million in fresh funding at a $12 billion valuation, the Nvidia and Google Ventures-backed company said on Wednesday, doubling its value in just t... |
| 21.01.2026 | OpenEvidence Raises $250M in Series D |
MIAMI, FL, OpenEvidence, a widely-used AI platform by doctors in America, announced that it closed a Series D round of funding of $250 million.
>> Click here for more funding data on OpenEvidence
>> To export OpenEvidence fundi... |
| 21.01.2026 | Healthcare AI startup OpenEvidence raises $250M at $12B valuation
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | OpenEvidence Inc., a startup that develops artificial intelligence software for physicians, today disclosed that it has raised $250 million in funding.
Thrive Capital and DST Global led the investment. It values OpenEvidence at $12 billion,... |
| 21.01.2026 | OpenEvidence Raises $250M in Series D Funding | OpenEvidence, a Miami, FL-based provider of an AI platform for doctors, raised $250M in Series D funding, at $12 Billion valuation.
The round was led by Thrive Capital and DST Global. Previous investors included Sequoia, Google Ventures, Nv... |
| 21.01.2026 | OpenEvidence, the ‘ChatGPT for Doctors’ AI startup, hits $12B valuation in $250M Thrive-led round | OpenEvidence just pulled off one of the fastest valuation climbs in healthcare AI. The Miami-based startup, often described as “ChatGPT for doctors,” closed a $250 million funding round led by Thrive Capital and DST, valuing it at $12 billi... |
| 21.01.2026 | OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion | OpenEvidence raised money at a valuation of $12 billion in a round led by Thrive and DST.
The startup is widely known as “ChatGPT for doctors” and has seen meteoric growth from its $1 billion valuation a year ago.
CEO Daniel Nadler told CNB... |
| 22.10.2025 | Tech Spend Soars, But Enterprises Still Struggle to Scale AI | Image: Adobe Stock
Businesses worldwide are investing more in AI than ever before, yet many still struggle to translate that investment into large-scale success.
That’s according to the 2025 Kyndryl Readiness Report, which surveyed 3,700 se... |
| 21.10.2025 | OpenEvidence Raises $200 Million to Bring Verified AI to Clinicians | OpenEvidence Secures $200 Million Funding for AI Medical Platform
The healthcare AI startup, OpenEvidence, has raised $200 million in a new funding round. This places their valuation at $6 billion. The funding round was led by Google Ventur... |
| 21.10.2025 | HLTH 2025 Day 1 Summary & Insights: AMA Launches AI Governance Center, Google Cloud, Microsoft, ChatGPT for Medicine | Core Clinical & Diagnostic Innovations
Real-World Evidence (RWE) Agent Pilot: Atropos Health, in collaboration with Microsoft, is piloting the Atropos Evidence™ Agent at Stanford Health Care. This expert agent generates patient-specific... |
| 20.10.2025 | Medical search engine startup OpenEvidence closes $200M investment led by GV
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | OpenEvidence Inc., the developer of an artificial intelligence search engine for doctors, today announced that it has closed a $200 million investment.
The Series C round was led by Alphabet Inc.’s GV fund. Sequoia, Kleiner Perkins, Blackst... |
| 16.10.2025 | Microsoft Unveils Expanded Dragon Copilot: AI Transformation for Nursing and Revenue Cycle | What You Should Know:
– Microsoft unveiled significant AI innovations for its leading clinical assistant, Dragon Copilot, leveraging ambient and generative technologies to enhance the patient journey, reduce workflow burden, and strengthen ... |
| 12.09.2025 | M&A: OpenEvidence Acquires Amaro to Enhance AI-Powered Advertising | What You Should Know:
– OpenEvidence, a medical search and AI platform for clinicians, has acquired Amaro, an AI-native advertising company backed by Google Ventures and Greycroft. Financial details of the acquisition were not disclosed.
– ... |
| 22.07.2025 | OpenEvidence Reshapes Healthcare with AI, Secures $210M Funding | OpenEvidence secured $210M in Series B funding, valuing the leading medical AI platform at $3.5 billion. It simultaneously launched DeepConsult, a revolutionary, free AI agent for all verified U.S. physicians. This platform combats clinicia... |
| 16.07.2025 | OpenEvidence Secures $210M, Launches Free AI Agent for Clinicians | What You Should Know:
– OpenEvidence, the most widely used medical search and AI application among verified U.S. clinicians raises $210M in Series B funding round, valuing the company at $3.5 billion. The round was co-led by Google Ventures... |
| 16.07.2025 | OpenEvidence: $210 Million Raised At $3.5 Billion Valuation For Medical Research Platform | OpenEvidence, the leading medical search and AI application for U.S. clinicians, has announced a $210 million Series B funding round, valuing the company at $3.5 billion. The round was co-led by Google Ventures and Kleiner Perkins, with fol... |
| 15.07.2025 | OpenEvidence Raises $210M Series B |
CAMBRIDGE, MA, OpenEvidence, the most widely used medical search and AI application among verified U.S. clinicians, today announced a $210 million Series B round at a $3.5 billion valuation.
>> Click here for more funding data on Ope... |
| 15.07.2025 | OpenEvidence Raises $210M in Series B Funding | OpenEvidence, a Cambridge, MA-based medical search and AI application provider, raised $210M in Series B funding.
Backers included Sequoia Capital, Coatue, Conviction, and Thrive.
The company intends to use the funds to expand strategic con... |
| 15.07.2025 | OpenEvidence raises $210M on $3.5B valuation to expand AI-powered medical search and decision tools
Join theCUBE Alumni Trust Network
Send us a News Tip
EXTRACT THE SIGNAL FROM THE NOISE
Cookies | Healthcare-focused artificial intelligence platform company OpenEvidence Inc. revealed today that it has raised $210 million in new funding on a $3.5 billion valuation to expand its strategic content partnerships and scale its AI-powered cl... |
| 07.07.2025 | Rock Health Report: AI Dominates Digital Health Investment in First Half of 2025 | Image Credit: Rock Health H1 2025 Report
What You Should Know:
– The first half of 2025 saw a modest increase in digital health venture funding, reaching $6.4B across 245 deals for US-based digital health companies, according to Rock Health... |
| 26.03.2025 | Healthcare And Security Led For New Unicorns In February | 9 Shares Email Facebook Twitter LinkedIn
Nine companies joined The Crunchbase Unicorn Board in February with healthcare and cybersecurity the leading sectors for new unicorn companies.
While by itself it wasn’t the leading sector for unicor... |
| 22.02.2025 | OpenEvidence: A New Dawn in Medical AI | In the ever-evolving landscape of healthcare, a new player has emerged, shining brightly on the horizon. OpenEvidence, an AI-enabled medical information platform, has recently reached a staggering $1 billion valuation after securing Series ... |
| 21.02.2025 | Medical information platform OpenEvidence reaches $1B valuation | Photo: Hero Images/Getty Images
OpenEvidence, an AI-enabled medical research aggregate platform for doctors, has closed a Series A funding round with Sequoia Capital, boosting its valuation to $1 billion and bringing its total raise to more... |
| 20.02.2025 | Healthcare AI startup OpenEvidence raises $75M in Sequoia-led round to scale AI for doctors, joins unicorn club | Healthcare AI startup OpenEvidence has secured $75 million in new funding to expand its chatbot designed for doctors. The Series A round, led by Sequoia, pushes the company’s valuation to $1 billion, placing it in unicorn territory.
Based i... |
| 20.02.2025 | OpenEvidence Closes Series A Funding | OpenEvidence, a Cambridge, MA-based provider of an AI copilot for doctors, raised an undisclosed amount in Series A funding at $1 Billion valuation
The round was led by Sequoia Capital.
The company intends to use the funds to train its next... |
| 19.02.2025 | OpenEvidence raises $75M to become the ChatGPT for doctors
Your vote of support is important to us and it helps us keep the content FREE.
One click below supports our mission to provide free, deep, an... | The healthcare focused chatbot startup OpenEvidence has closed on $75 million in funding from the venture capital firm Sequoia Capital Operations LLC in a round that values it at more than $1 billion.
The round, which came to light today vi... |
| 11.12.2024 | 2025 to Test AI Ideas for Viability: Sequoia's 3 Predictions If 2024 was AI's primordial soup year, 2025 will be about the foundations solidifying, according to David Cahn, partner at Sequoia Capital | Venture capital giant Sequoia Capital is among many to have bet big on artificial intelligence in 2024. An investor in heavyweights such as OpenAI, xAI, Safe Superintelligence, and others, the VC has invested a staggering total of approxima... |
| - | OpenEvidence | “The leading medical information platform.” |
| - | OpenEvidence | - |
